Naloxegol
![]() | |
| Clinical data | |
|---|---|
| Trade names | Movantik |
| AHFS/Drugs.com | movantik |
| [[Regulation of therapeutic goods |Template:Engvar data]] | |
| Pregnancy category |
|
| Routes of administration | Oral |
| ATC code | |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Protein binding | ~4.2% |
| Metabolism | Hepatic (CYP3A) |
| Elimination half-life | 6–11 h |
| Excretion | Feces (68%), urine (16%) |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| ChEBI | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C34H53NO11 |
| Molar mass | 651.785 |
| 3D model (JSmol) | |
| |
| |
|
WikiDoc Resources for Naloxegol |
|
Articles |
|---|
|
Most recent articles on Naloxegol |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Naloxegol at Clinical Trials.gov Clinical Trials on Naloxegol at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Naloxegol
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Naloxegol Discussion groups on Naloxegol Directions to Hospitals Treating Naloxegol Risk calculators and risk factors for Naloxegol
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Naloxegol |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Naloxegol (INN; NKTR-118), or PEGylated naloxol,[1] trade name Movantik, is a peripherally-selective opioid antagonist under development by AstraZeneca, licensed from Nektar, for the treatment of opioid-induced constipation.[2]
See also
References
- ↑ Roland Seifert; Thomas Wieland; Raimund Mannhold (17 July 2006). G Protein-Coupled Receptors as Drug Targets: Analysis of Activation and Constitutive Activity. John Wiley & Sons. p. 227. ISBN 978-3-527-60695-5. Retrieved 14 May 2012. Unknown parameter
|coauthors=ignored (help) - ↑ "Nektar | R&D Pipeline | Products in Development | CNS/Pain | Oral Naloxegol (NKTR-118) and Oral NKTR-119". Retrieved 2012-05-14.
- Pages with script errors
- Pages with citations using unsupported parameters
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without UNII source
- Articles containing unverified chemical infoboxes
- Drugs
- Alkenes
- Diols
- Morphinans
- Opioid antagonists
- Synthetic opioids
